Insiders · IRD

Jay Pepose

Director at Ocuphire Pharma, Inc. (IRD) since June 2021

Jay Pepose has filed 13 insider reports with the SEC since June 2021, as director at Ocuphire Pharma, Inc. (IRD). Jay Pepose made no open-market purchases or sales in the last 12 months. The latest filing, on June 13, 2024, reports grant or award at Ocuphire Pharma, Inc. (IRD).

Filings
13
Companies
1
Bought on market
$90.1K
Sold on market
None

Companies where Jay Pepose is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Ocuphire Pharma, Inc. logo
IRD
Ocuphire Pharma, Inc.
Directorsince June 2021180,458$90.1K$4.32$3.99-7.6%Jun 13, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Jay Pepose with

Other insiders at the same companies

Questions about Jay Pepose

What is Jay Pepose's role at Ocuphire Pharma, Inc.?
Jay Pepose reports to the SEC as director at Ocuphire Pharma, Inc. (IRD), according to the latest filing on June 13, 2024.
How many shares does Jay Pepose own?
After the latest filing that states it, Jay Pepose directly owned 180,458 shares of Ocuphire Pharma, Inc. (IRD). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jay Pepose bought or sold stock recently?
The most recent open-market purchase was on December 13, 2021: bought 8,250 shares of Ocuphire Pharma, Inc. (IRD) for $30.1K at an average of $3.65.
How do I get alerts when Jay Pepose files?
Follow Jay Pepose on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jay Pepose (SEC CIK 0001866191). Totals count each trade once, skipping amendments whose original is on file, from Jun 9, 2021 on. View on SEC EDGAR · Get this as JSON